Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [presentation]
Presentation
Overview
occurs within event
University of Minnesota 12th Annual Robert Hebbel Research Day
participant
Ahmed, I.
Presenter
Dahiya, R.
Presenter
House, Chad M., BS, RDCS, FASE
Presenter
Nelson, William B., MD
Presenter
Zhu, Dennis W., MD
Presenter
Research
keywords
Heart Diseases
Metabolic Syndrome
Mortality
Prevention
Retrospective Studies
Surgery